Literature DB >> 26284476

A bird's eye view of NK cell receptor interactions with their MHC class I ligands.

Philippa M Saunders1, Julian P Vivian2,3, Geraldine M O'Connor1, Lucy C Sullivan1, Phillip Pymm2,3, Jamie Rossjohn2,3,4, Andrew G Brooks1.   

Abstract

The surveillance of target cells by natural killer (NK) cells utilizes an ensemble of inhibitory and activating receptors, many of which interact with major histocompatibility complex (MHC) class I molecules. NK cell recognition of MHC class I proteins is important developmentally for the acquisition of full NK cell effector capacity and during target cell recognition, where the engagement of inhibitory receptors and MHC class I molecules attenuates NK cell activation. Human NK cells have evolved two broad strategies for recognition of human leukocyte antigen (HLA) class I molecules: (i) direct recognition of polymorphic classical HLA class I proteins by diverse receptor families such as the killer cell immunoglobulin-like receptors (KIRs), and (ii) indirect recognition of conserved sets of HLA class I-derived peptides displayed on the non-classical HLA-E for recognition by CD94-NKG2 receptors. In this review, we assess the structural basis for the interaction between these NK receptors and their HLA class I ligands and, using the suite of published KIR and CD94-NKG2 ternary complexes, highlight the features that allow NK cells to orchestrate the recognition of a range of different HLA class I proteins.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  CD94-NKG2; human leukocyte antigen; killer cell immunoglobulin-like receptors; natural killer cell receptors

Mesh:

Substances:

Year:  2015        PMID: 26284476     DOI: 10.1111/imr.12319

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  49 in total

1.  Natural Killer Cell Recruitment and Activation Are Regulated by CD47 Expression in the Tumor Microenvironment.

Authors:  Pulak Ranjan Nath; Dipasmita Pal-Nath; Ajeet Mandal; Margaret C Cam; Anthony L Schwartz; David D Roberts
Journal:  Cancer Immunol Res       Date:  2019-07-30       Impact factor: 11.151

2.  Recognition of nectin-2 by the natural killer cell receptor T cell immunoglobulin and ITIM domain (TIGIT).

Authors:  Felix A Deuss; Benjamin S Gully; Jamie Rossjohn; Richard Berry
Journal:  J Biol Chem       Date:  2017-05-17       Impact factor: 5.157

3.  Unconventional Peptide Presentation by Major Histocompatibility Complex (MHC) Class I Allele HLA-A*02:01: BREAKING CONFINEMENT.

Authors:  Soumya G Remesh; Massimo Andreatta; Ge Ying; Thomas Kaever; Morten Nielsen; Curtis McMurtrey; William Hildebrand; Bjoern Peters; Dirk M Zajonc
Journal:  J Biol Chem       Date:  2017-02-08       Impact factor: 5.157

Review 4.  Strategies for the measurements of expression levels and half-lives of HLA class I allotypes.

Authors:  Malini Raghavan; Brogan Yarzabek; Anita J Zaitouna; Sujatha Krishnakumar; Daniel S Ramon
Journal:  Hum Immunol       Date:  2019-02-05       Impact factor: 2.850

Review 5.  Killers 2.0: NK cell therapies at the forefront of cancer control.

Authors:  Jonathan J Hodgins; Sarwat T Khan; Maria M Park; Rebecca C Auer; Michele Ardolino
Journal:  J Clin Invest       Date:  2019-09-03       Impact factor: 14.808

Review 6.  Missing or altered self: human NK cell receptors that recognize HLA-C.

Authors:  Hugo G Hilton; Peter Parham
Journal:  Immunogenetics       Date:  2017-07-10       Impact factor: 2.846

7.  The molecular basis of how buried human leukocyte antigen polymorphism modulates natural killer cell function.

Authors:  Philippa M Saunders; Bruce J MacLachlan; Phillip Pymm; Patricia T Illing; Yuanchen Deng; Shu Cheng Wong; Clare V L Oates; Anthony W Purcell; Jamie Rossjohn; Julian P Vivian; Andrew G Brooks
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-13       Impact factor: 11.205

8.  Variations in HLA-B cell surface expression, half-life and extracellular antigen receptivity.

Authors:  Brogan Yarzabek; Anita J Zaitouna; Eli Olson; Gayathri N Silva; Jie Geng; Aviva Geretz; Rasmi Thomas; Sujatha Krishnakumar; Daniel S Ramon; Malini Raghavan
Journal:  Elife       Date:  2018-07-10       Impact factor: 8.140

9.  The molecular basis for peptide repertoire selection in the human leucocyte antigen (HLA) C*06:02 molecule.

Authors:  Jesse I Mobbs; Patricia T Illing; Nadine L Dudek; Andrew G Brooks; Daniel G Baker; Anthony W Purcell; Jamie Rossjohn; Julian P Vivian
Journal:  J Biol Chem       Date:  2017-08-30       Impact factor: 5.157

10.  Poorly cytotoxic terminally differentiated CD56negCD16pos NK cells accumulate in Kenyan children with Burkitt lymphomas.

Authors:  Catherine S Forconi; Cormac P Cosgrove; Pryia Saikumar-Lakshmi; Christina E Nixon; Joslyn Foley; John Michael Ong'echa; Juliana A Otieno; Galit Alter; Christian Münz; Ann M Moormann
Journal:  Blood Adv       Date:  2018-05-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.